Planet Labs PBC (PL) Spending and interest coverage
- R&D / revenue · 12 months: Value 33.86%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 16.53%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 33.86% | Research and development expense / revenue. Period ending 2026-07-31. $128.10M ÷ $378.28M × 100 ≈ 33.86% |
| Stock-based compensation / revenue · 12 months | 16.53% | Share-based compensation / revenue. Period ending 2026-07-31. $62.52M ÷ $378.28M × 100 ≈ 16.53% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 128.10M USD | Research and Development Expense |
| Revenue | 378.28M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 62.52M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -102.74M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $128.10M | $378.28M | $62.52M | $-102.74M | (m) | 33.86% | 16.53% | (m) | (m) |
| 2026-04-30 | $117.09M | $335.61M | $58.91M | $-107.19M | (m) | 34.89% | 17.55% | (m) | (m) |
| 2026-01-31 | $106.75M | $307.73M | $54.99M | $-95.07M | (m) | 34.69% | 17.87% | (m) | (m) |
| 2025-10-31 | $97.51M | $282.46M | $51.49M | $-78.44M | (m) | 34.52% | 18.23% | (m) | (m) |
| 2025-07-31 | $95.40M | $262.47M | $49.84M | $-82.70M | (m) | 36.35% | 18.99% | (m) | (m) |
| 2025-04-30 | $98.49M | $250.18M | $47.95M | $-104.32M | (m) | 39.37% | 19.17% | (m) | (m) |
| 2025-01-31 | $101.01M | $244.35M | $48.48M | $-116.12M | (m) | 41.34% | 19.84% | (m) | (m) |
| 2024-10-31 | $106.47M | $241.65M | $48.99M | $-130.67M | (m) | 44.06% | 20.27% | (m) | (m) |
| 2024-07-31 | $114.25M | $235.76M | $49.76M | $-155.92M | (m) | 48.46% | 21.10% | (m) | (m) |
| 2024-04-30 | $113.74M | $228.43M | $54.85M | $-159.63M | (m) | 49.79% | 24.01% | (m) | (m) |
| 2024-01-31 | $116.34M | $220.70M | $57.13M | $-169.75M | $0.00 | 52.71% | 25.89% | (m) | Reported |
| 2023-10-31 | $119.76M | $214.82M | $60.31M | $-178.52M | (m) | 55.75% | 28.08% | (m) | (m) |
| 2023-07-31 | $114.36M | $209.14M | $67.15M | $-173.29M | (m) | 54.68% | 32.11% | (m) | (m) |
| 2023-04-30 | $114.35M | $203.83M | $71.08M | $-172.65M | (m) | 56.10% | 34.87% | (m) | (m) |
| 2023-01-31 | $110.92M | $191.26M | $75.54M | $-175.68M | $0.00 | 57.99% | 39.50% | (m) | Reported |
| 2022-10-31 | $106.25M | $175.43M | $89.18M | $-190.19M | $1.02M | 60.57% | 50.83% | -186.10× | Reported |
| 2022-07-31 | $93.61M | $157.42M | $74.38M | $-175.87M | $3.63M | 59.46% | 47.25% | -48.40× | Reported |
| 2022-04-30 | $79.30M | $139.38M | $58.68M | $-157.50M | $6.25M | 56.90% | 42.10% | -25.22× | Reported |
| 2022-01-31 | $66.68M | $131.21M | $41.96M | $-128.05M | $8.77M | 50.82% | 31.98% | -14.60× | Reported |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $43.83M | $113.17M | $14.01M | $-87.44M | $9.45M | 38.73% | 12.38% | -9.26× | Reported |
| 2020-01-31 | $37.87M | $95.74M | $5.07M | $-106.46M | $6.95M | 39.56% | 5.30% | -15.33× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.